July 26, 2025 a 07:43 am
ELV: Fundamental Ratio Analysis - Elevance Health Inc.
Elevance Health Inc. is a leader in the healthcare sector with strong digital and care solutions. The company has shown consistent performance and has a favorable outlook due to its robust service portfolio catering to a wide consumer base. Investors may find this stock interesting due to its stable fundamentals and potential for growth.
Fundamental Rating
Elevance Health Inc. shows a solid fundamental rating with strengths in cash flow and equity returns, though modest in price metrics.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return On Equity | 4 | |
| Return On Assets | 4 | |
| Debt To Equity | 3 | |
| Price To Earnings | 2 | |
| Price To Book | 3 |
Historical Rating
The historical scores reflect consistent performance, particularly in cash flow and asset management metrics.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-25 | 4 | 5 | 4 | 4 | 3 | 2 | 3 |
| Past (null date) | 0 | 5 | 4 | 4 | 3 | 2 | 3 |
Analyst Price Targets
Analysts maintain a positive outlook, with a solid consensus on potential stock appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| $500 | $465 | $482.5 | $482.5 |
Analyst Sentiment
The analyst sentiment indicates a strong inclination towards buying, with no sell recommendations.
| Recommendation | Count | Distribution |
|---|---|---|
| Buy | 28 | |
| Hold | 9 | |
| Strong Buy | 0 | |
| Sell | 0 | |
| Strong Sell | 0 |
Conclusion
Elevance Health Inc.'s stock shows a compelling investment opportunity due to its strong financial fundamentals and positive analyst outlook. While the price metrics are moderate, the company's strategic positioning in the healthcare sector and consistent financial performance provide a stable growth prospect. Investors should consider the potential upside stemming from the increasing demand for comprehensive healthcare solutions. However, external market factors and regulatory changes remain potential risks to monitor.